{"title": "Kidney disease killer vulnerable to targeted nano therapy", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/chronic_illness.xml", "value": "Kidney disease killer vulnerable to targeted nano therapy"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/03/190304182111.htm"}], "link": "https://www.sciencedaily.com/releases/2019/03/190304182111.htm", "summary": "By loading a chelation drug into a nano-sized homing device, researchers have reversed in an animal model the deadliest effects of chronic kidney disease, which kills more people in the United States each year than breast or prostate cancer.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/chronic_illness.xml", "value": "By loading a chelation drug into a nano-sized homing device, researchers have reversed in an animal model the deadliest effects of chronic kidney disease, which kills more people in the United States each year than breast or prostate cancer."}, "published": "Mon, 04 Mar 2019 18:21:11 EST", "published_parsed": [2019, 3, 4, 23, 21, 11, 0, 63, 0], "id": "https://www.sciencedaily.com/releases/2019/03/190304182111.htm", "guidislink": false}